Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X      
Users Online : 155  
 
Home About Us Current Issue Online First Archive Search Author Services Register Login Contact

 » Editorial Statement
 » Peer Review Process
 » Guiding Principal
 » Types of Manuscript
 » Authorship Criteria
 » Submitting Manuscript
 » Preparation of Manuscript
 
 » Manuscript details
 » Manuscript help
 » Author Rewards
 » Final content draft
 » Services in detail
 » Service charges
 
 » Author Rewards
 » Reviewers
 » Advertisers
 » Access Statistics
 » Resources
 


 
The Manuscript Instructions    Use  JCDR Pre Publishing New  for submitting manuscripts.
   
Editorial Statements         

  • JCDR strongly supports research that will benefit medical science and discourages the publication of articles that merely represent pre-established and repetitive facts. However, at times, the journal does allow publication of articles that may have been reported in Western literature but have not been reported from the developing and the underdeveloped world. This is with a dual aim, to promote medical publication from these countries and to recognize the fact that disease and disease behaviour may vary widely between populations.

  • JCDR provides services, if required by authors, in view of supporting them to write good quality articles. In return it charges nominal fees. Details of which can be found under author services.

  • The philosophy of publishers behind JCDR is to promote research publication from less privileged parts of the world. The publishers do not propose to earn profit from the journal services. Hence most services provided are at par or below the costs to the publishers.

  • JCDR welcomes and encourages authors who do not wish to use these services.

  • There is no charge what so ever for submission of manuscripts that is prepared by the authors themselves.

  • The publisher (PSF, India) rewards articles published in this journal for which authors did not avail any paid service from JCDR.

  • JCDR editorial board and publisher take proactive steps in remaining unbiased to authors who avail or do not avail paid services.

  • Under no circumstances / incentive will JCDR publish an article without merit and peer review.

  • The criteria for acceptance, format of manuscript and peer review process for authors who use or do not use paid services remains identical.

  • The time table of events after submission of an article detailed below refers to those authors who do not utilize the paid services of JCDR.
 
Editorial & Peer Review Process

Time table

The Editorial board at JCDR follows a rigid time table and as far as possible tries to adhere to it.
     
1 Time from receiving manuscript to initial (provisional) approval/disapproval by editorial board 5 days
2 Time from approval to completion of peer review 3 week
3 Time for authors to send back the correction or explanations to comments by peer reviewers 3 week
4 Time for final acceptance by the editorial board based on peer review process 1 week
5 Time for authors to send in the final corrected draft 2 week
6 Time for JCDR to set up the article in its format 4 days
7 Time for authors to do the final proof reading 3 days

The manuscripts will be reviewed for possible publication on the understanding that they are being submitted only to one journal at one time and have not been published, simultaneously submitted, or accepted for publication elsewhere.

  1. As the first step, the editors review all the submitted manuscripts. Manuscripts that are not original enough, indicate serious scientific flaws, or do not convey significant messages are rejected (read editorial statements).

  2. All the manuscripts that are submitted are duly acknowledged.

  3. Each manuscript is initially reviewed by 3 members of the editorial team. They inform the author if the article has been accepted for peer review or has been rejected. If rejected, the corresponding author will be informed via an email.

  4. If approved for peer review the article is then placed under the supervision of one (out of the initial three) member of the editorial team. The manuscripts are then de-identified and sent to two or more expert reviewers. The comments of the reviewers are forwarded to the author for explanation or draft improvement.

  5. After receipt of the answers or revised draft from the authors in response to the peer review comments, the coordinating editor takes the final decision regarding the acceptance of the manuscript. The whole process is completed within 6-7 weeks.

  6. Language edit: The manuscripts that are accepted are edited for grammar, punctuation, style, and format. Page proofs will be sent to the author and have to be returned within three days. Any correction or modification made to the manuscript after that period may not be included.

  7. Note: the emails containing original manuscripts, which have been rejected, will be removed from our system within 30 days of editorial board communicating its decision.
 
Guiding Principle Behind Manuscript Preparation

You must prepare your manuscripts in accordance with the “Uniform requirements for Manuscripts submitted to Biomedical Journal” developed by the International Committee of Medical Journal Editors in October 2001. The general and specific requirements of the JCDR are summarised below. Before sending a manuscript, contributors are requested to check for the latest instructions.
 
Types Of Manuscript And Word Limits

  • Original articles : Randomly controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, cost effectiveness analyses, case-control series, and surveys with a reasonably high response rate. Up to 3000 words excluding the abstract and the references.

  • Review articles (including those related to the Ethics forum, the Education forum, E-Medicine, and so on): Systemic critical assessment of literature and data sources. Up to 4000 words excluding the abstract and the references.

  • Case reports or briefs: Novel/interesting/extremely rare cases or rare presentations can be reported. Cases with clinical significance or implications will be given priority. Up to 1200 words excluding references and abstract and up to 15 references.

  • Images in medicine : A short history, photograph, differential diagnosis, and discussion of a classic and/or rare case. Should not be more than 1000 words excluding up to ten references.

  • Letter to the Editor : Should reflect short, decisive observation. Up to 500 words and five references.

  • Clinicians Corner : Short narrative of a real life experience in the medical sphere during practice. Should contain a clear, informative, educative, or enlightening message. Up to 600 words.

  • Announcements : of conferences, meetings, courses, awards, and other events of interest to the readers should be submitted with the name and address of the person from whom additional information can be sought. Up to 100 words.
Authorship Criteria


To ensure authorship for the submitted manuscripts, the contributors should meet the following three conditions:

  • Conception and design, acquisition of data, or analysis and interpretation of data has been done by the author

  • Either drafting the article or revising it critically for important intellectual content has been done by the author

  • The final approval of the version to be published has been given by the author.
    Each contributor should have participated sufficiently in the work to be allowed to take public responsibility for suitable portions of the content.

Naming Order for Contributors
The order of naming the contributors should be based on the relative contribution of the contributor towards the study and the writing of the manuscript. Once submitted, the order cannot be changed without the written consent of all the contributors.

Number of Contributors
In the event of a study carried out in a single institute, the number of contributors should not exceed eight. For case-reports, images, letters to the editor, and review articles, the number of contributors should not exceed five. There should be a written justification if the number of contributors exceeds five. If the JCDR feels necessary it may ask for description of the contribution of authors towards the manuscript.

Guarantor
One or more author should take responsibility for the integrity of the work from the inception to the publishing of the article. This author will be designated as the guarantor.

Prerequisite for review articles
A review article can be written only by individuals who have done substantial work in a particular field. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript. The journal expects the contributors to provide post-publication updates on the subject of review. The update should be brief and should include the expected advancements in the field after the publication of the article. The update should be sent as a letter to the editor as and when major developments occur in the particular field.


Submitting Manuscript

Please use our Manuscript Management Portal : JCDR Pre Publishing New  for submitting manuscripts and knowing their post-submission status. For any problems related to submission please feel free to write to editor@jcdr.net.

During Sept - Oct 07 if the author faces any difficulty at the JCDR Pre Publishing New, they can alternatively submit manuscript via email at submit@jcdr.net . While doing so the author should clearly mention what problems they faced at the JCDR Pre Publishing. This feedback will help us improve the Manuscript Management Portal further.

We do not accept print submission.

 

Preparation Of Manuscript

  • Observational and experimental articles should be divided into sections, such as Introduction, Materials & Methods, Results, Discussion, References, Tables, Figures, Figure legends, and Acknowledgment.

  • Use double spacing throughout.

  • The language should be British English.

Title Page
The title page should carry the following details:

  • The covering letter must include the following information:
  1. An Undertaking that the material has not been published or submitted elsewhere
  2. A statement of financial or other relationships that might lead to a conflict of interest.
  3. Whether or not support was received from this journal in preparation of the manuscript.
  4. Whether the authors wish to be considered for a reward if the article is accepted.
  • The type of manuscript, for e.g, original article, case Report, and so on

  • The title of the article, which should be concise, but informative;

  • The Running title or short title not more than 50 characters;

  • The complete name [ avoid initials ] by which each contributor is known, with his or her highest academic degree(s) and institutional affiliation;

  • The name of the department(s) and institution(s) to which the work should be attributed;

  • The name, address, phone number, and e-mail address of the contributor who is responsible for corresponding about the manuscript;

  • The total number of pages, the total number of photographs, and word counts for the abstract and the text (excluding the references);

  • The source(s) of support in the form of grants, equipment, drugs, or all of these;

  • Acknowledgement, if any; and

  • The organisation, place, and exact date on which the manuscript was read, if ever.

     

  • Name of Three Referees with email IDs whom you will like to suggest as referee for your manuscript.

     

  • Name of Two referees whom you will not like to send your manuscript for assessment

 

Abstract Page
The second page should carry the complete title of the manuscript and an abstract. The length of the abstract should be restricted to 200 words for case reports and brief reports and 350 words for original articles. The abstract should be structured to include the Context (Background), Aims, Settings and Design, Methods and Material, Statistical Analysis used, Results and Conclusions. Three to ten keywords should be provided below the abstract.

Key Messages
Provide three to six short key messages for all the original articles and one or two for the case reports. These messages should highlight the study, report, or review. The messages will be printed along with the text in highlighted boxes.

 Key Words

 These should be put in after reference to standard key words in pubmed. 

Introduction
State the purpose of the article and summarise the rationale for the study or observation.

Methods

  • Describe the selection of the observational or experimental subjects, such as patients and laboratory animals. Include the controls used for each experiment.

  • Identify the age, sex, and other important characteristics of the subjects.

  • Identify the methods, apparatus, and procedures in sufficient detail. Provide references to established methods, and describe briefly methods that have been published but are not well known.

  • Describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all the drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

  • Reports of random clinical trials should provide information regarding all major study elements, including the protocol, assignment of interventions, and the method of masking.( http://www.consort-statement.org).

  • Authors submitting review articles should include a section describing the methods used for locating, selecting, extracting, and synthesising data. These methods should also be summarised in the abstract.

Ethics

  • While reporting experiments on human subjects, you should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975 that was revised in 2000. (http://www.wma.net/e/policy/17-c_e.html.)

  • Do not use names or initials of patients or hospitals and/or hospital telephone numbers especially in illustrative material.

  • While reporting experiments on animals, indicate whether you adhered to the guidelines of an institution or national research council governing the care and use of laboratory animals.

Statistics

  • Whenever possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty.

  • Report losses to observation resulting from conditions, such as dropouts from a clinical trial.

  • Include a general description of methods in the Methods section.

  • While summarizing the data in the Results section, specify the statistical methods used to analyse them.

  • Avoid non-technical uses of technical terms in statistics. Define statistical terms, abbreviations, and most symbols.

Results


Present the results in a logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations. Instead, emphasise on or summarise only important observations.

 

Discussion

  • Emphasise the new and important aspects of the study and the conclusions that result from them.

  • Do not repeat in detail the data or other material provided in the Introduction or Results section. Include in the Discussion section the implications of the findings for the present and for future research and their limitations. Relate the observations to other relevant studies.

  • Contributors should refrain from commenting on economic benefits and costs unless their manuscript includes economic data and analyses.

  • Avoid claiming priority and alluding to work that has not been completed.

  • State new hypotheses when warranted, but clearly label them as such.

  • Recommendations may be included only if appropriate.

Acknowledgments

As an appendix to the text, one or more statements should specify

  1. The contributions that should be acknowledged but do not justify authorship,
  2. Acknowledgment of technical help; and
  3. Acknowledgment of financial and material support, specifying the nature of the support.
  4. Any paid support received from JCDR in preparation of the manuscript.

References

  • The references / biblography should be in Vancouver style. For full details on this refer to the following link to university of Queensland (http://www.library.uq.edu.au/training/citation/vancouv.pdf )

  • References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure.

  • The titles of journals should be abbreviated according to the style used in Index Medicus.

  • Use the complete name of the journal for non-indexed journals.

  • Avoid using abstracts as references.

  • Information from manuscripts submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source.

  • Avoid citing a “personal communication” unless it provides essential information that is otherwise unavailable from public sources. In such an event, the name of the person and the date of communication should be cited in parentheses in the text.

  • For scientific articles, contributors should obtain written permission and confirmation of accuracy from the source of a personal communication.

Tables & Figures

  • JCDR is an online only journal. It does not differentiate between tables and figures in numbering them as images are made for both.  All tables and Figures should be numbered in Arabic numerals consecutively in the order of their first citation in the text. (  example Table/Fig 1, Table/Fig 2......)
     
  • Tables should be self-explanatory and should not duplicate textual material.
     
  • Tables with more than 12 columns and 30 rows are not acceptable.

  • Place the explanatory matter in footnotes, not in the heading.
  • Explain in footnotes all non-standard abbreviations that are used in each table.
  • Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
  • For footnotes, use the following symbols in this sequence: *, †, ‡, §, ||, , **, ††, ‡‡
  • Labels, numbers, and symbols should be clear and of uniform size.
  • When graphs, scatter-grams or histograms are submitted, the numerical data on which they are based should also be supplied.
  • If photographs of people are used, either the subjects must not be identifiable or their pictures must be accompanied by written permission to use the photograph.
  • If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for figures for such figures.
  • The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to the desired size.
     

Protection of Patients’ Rights to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, and pedigrees unless the information is essential for scientific purposes. The patient, parent, or guardian provides a written consent for the publication. After the consent has been obtained, it should be indicated in the article. A copy of the consent should be attached with the cover letter.

Sending a revised manuscript

While submitting a revised manuscript, contributors should send as an attachment to the e-mail the revised manuscript with the changes indicated using the track change feature of Microsoft Word and a counter comment to each comment..


Copyrights

The whole of the literary matter in the JCDR is copyright of its publishers. For reproduction refer to disclaimer and copyrights.

Ombudsman

For issues related to this journal, write to Dr. Hemant Jain at editor-in-chief@jcdr.net.


Checklist

Check the items as applicable and send as an e-mail attachment with the manuscript
Manuscript Title

Covering letter

  • Signed by all contributors.
  • Previous publication / presentations mentioned.
  • Source of funding mentioned.
  • Conflicts of interest disclosed.
  • Disclosure, if any paid service of JCDR used.
  • Desire to apply for rewards.


Authors

  • Middle name initials provided.
  • Author for correspondence identified, with e-mail address provided.
  • Author who will be guarantor of authenticity or the study, with e-mail address provided.
  • Number of contributors restricted as per the instructions.
  • Identity not revealed in paper except title page

Presentation and format

  • Matter written in double space .
  • Matter in Times New Roman font, Size 10.
  • Title page contains all the desired information .
  • Running title provided (not more than 50 characters).
  • Abstract page contains the full title of the manuscript.
  • Abstract of predefined length provided.
  • Structured abstract provided for an original article.
  • Key words provided.
  • Key messages provided.
  • Introduction of 75-100 words.
  • Headings in title case.
  • References cited in superscript without brackets.
  • References according to the journal’s instructions, punctuation marks checked

Language and grammar

  • Uniformly British English.
  • Abbreviations spelt out in full at the first instance. Abbreviated elsewhere.
  • Numerals from 1 to 10 spelt out.
  • Numerals at the beginning of the sentence spelt out.

Tables and figures

  • No repetition of data in tables and graphs and in text.
  • Actual numbers from which graphs are drawn have been provided.
  • Table and figure numbers in Arabic letters (not Roman).
  • Figure legends provided (not more than 50 words).
  • Patients’ privacy maintained (if not permission taken).
  • Credit note for borrowed figures/tables provided.

Contributors’ form (to be copied, signed, scanned and attached as an pdf file to the e-mail, Click here to download the pdf)

Manuscript Title: __________________________________________________________________________
I/we certify that I/we have participated adequately in the intellectual content, conception and design of this work or the analysis and interpretation of the data as well as the writing of the manuscript. I/we take public responsibility for the piece of work and have agreed to have my/our name listed as a contributor. I/we believe the manuscript represents valid work. Neither this manuscript nor any other manuscript with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere, except as described in the cover letter. I/we certify that all the data collected during the study has been presented in this manuscript and that no data from the study has been or will be published separately. I/we attest that, if requested by the editors, I/we will provide required data/information and will cooperate fully in obtaining and providing the data/information on which the manuscript is based, for examination purposes by the editors or their assignees. Financial interests, either direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this paper have been disclosed in the cover letter. All sources of external support have been mentioned in the cover letter.


I/We hereby transfer, assign, or otherwise convey all copyright ownership, including any and all rights incidental thereto, exclusively to the Journal of Clinical and Diagnostic Research, in the event that such work is published by the Journal of Clinical and Diagnostic Research. The Journal of Clinical and Diagnostic Research shall own the work, including 1) the copyright, 2) the right to grant permission to republish the article in whole or in part, with or without a fee, 3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution, and 4) the right to republish the work in a collection of articles in any other mechanical or electronic format.


We give the right to make necessary changes according to the request of the journal, correspond on our behalf, and to act as the guarantor for the manuscript to the corresponding author.


All persons who have made substantial contribution to the work reported in the manuscript, but are not contributors, are named in the Acknowledgment and have given me/us their written permission to be named. If I/we do not include an Acknowledgment, it means that I/we have not received substantial contribution from such persons and that the name of no contributor has been omitted.


Name Signature Date signed
1 ———————————— —————— —————

2 ———————————— —————— —————

3 ———————————— —————— —————

4 ———————————— —————— —————

5 ———————————— —————— ————— (up to 5 contributors for case reports/images/reviews)

6 ———————————— —————— —————

7 ———————————— —————— —————

8 ———————————— —————— ————— (up to 8 contributors for original studies, single center)



Sitemap | Login | Register | Feedback | Contact | Advertisers | Copyright & Disclaimer